fitri-handayani
The 2026 Nobel Prize in Chemistry has been awarded to two researchers whose work finally cracked a puzzle that had baffled scientists for more than a century: why living things build themselves from only one of two possible mirror-image forms of a molecule.
Henri B. Kagan, a French chemist, and Kenso Soai, a scientist from Japan, were honoured for discovering how nature selectively makes the correct version of a molecule while excluding its mirror counterpart, according to the Royal Swedish Academy of Sciences. The announcement was made in Stockholm on Wednesday, with the winners sharing a prize of 12.0 million Swedish Kroner, equivalent to roughly $1.25 million or £900,000.
At the heart of the discovery is a property known in organic chemistry as "chirality." The term describes molecules that exist in two forms that are mirror images of each other, much like a pair of human hands. The two versions are not identical — they are distinct arrangements of the same atoms — and they cannot be superimposed on one another, just as a left hand does not fit into a right-handed glove.
This phenomenon matters because amino acids, the fundamental building blocks of proteins, come in these paired mirror forms. Yet life on Earth uses only one of the two. Every living organism, from bacteria to humans, operates with a single favoured orientation of these molecules, a phenomenon known as homochirality.
The puzzle that Kagan and Soai addressed was how this preference arose in the first place. In a laboratory, ordinary chemical reactions typically yield a 50/50 mixture of both the left- and right-handed versions of a molecule — an outcome that would be useless for constructing the complex, uniform machinery of life.
Heiner Linke, who chairs the Nobel Committee for Chemistry, explained the significance of the pair's achievement during the announcement. He said the two laureates had provided a solution to a chemical mystery that is over a century old: how homochirality — the selective production of the correct version of a molecule — can emerge spontaneously. Linke described the chemical reactions they developed as "spectacular."
The work has profound implications for medicine, since the two mirror forms of a drug molecule can behave completely differently once inside the human body. One version might successfully fight a disease, while its mirror twin could be entirely inactive or even cause serious harm. The thalidomide tragedy of the late 1950s and early 1960s, in which a sedative prescribed to pregnant women caused severe birth defects, is often cited as a stark illustration of how the two forms of a molecule can have dramatically different effects.
By working out how to design chemical reactions that produce much more of the desired version of a molecule, Kagan and Soai opened the door to more precise and safer pharmaceutical manufacturing. Their methods allow chemists to steer reactions toward the specific mirror form they need, rather than settling for an equal mix of both.
The concept of chirality is often introduced using the simple analogy of hands. The Nobel Committee's own presentation illustrated this by showing a speaker holding up both hands to demonstrate how a left and right hand mirror each other but are not interchangeable. This everyday comparison helps explain why molecules with the same chemical formula can still be fundamentally different in how they interact with other molecules and with living tissue.
Kagan, based in France, and Soai, based in Japan, have spent decades exploring the mechanisms behind this selective molecular production. Their combined research has helped establish the theoretical and practical foundations for creating single-handed molecules on demand, a capability that underpins modern drug development and chemical synthesis.
The recognition places the two scientists among an elite group of researchers whose work has reshaped the understanding of the natural world at its most fundamental level. The Nobel Prize in Chemistry is one of the most prestigious scientific awards in the world, and this year's honour highlights a field of study that sits at the crossroads of biology, chemistry, and medicine.
The announcement was met with interest across the scientific community, which has long grappled with the question of why life settled on one particular set of mirror molecules. The answer provided by Kagan and Soai not only explains a natural phenomenon but also gives chemists a tool to replicate and exploit it in the laboratory.
Beyond drug manufacturing, the ability to control which version of a molecule is produced could influence fields ranging from agriculture to materials science, where the precise shape of a molecule often determines its function. The reactions developed by the laureates are expected to continue finding new applications as researchers build on their foundational insights.
The prize money, split between the two winners, comes with the traditional gold medal and diploma. The award ceremony is typically held in December, where the laureates will receive their honours and deliver lectures on their work.
For now, the 2026 Chemistry Nobel stands as a tribute to two researchers who answered a question that had lingered since the dawn of modern chemistry. Their work explains not only how life chooses its molecular building blocks but also how human chemists can make that same choice deliberately, with far-reaching consequences for science and medicine.
Comments (0)